ArticleNeuropharmacology2020

Endocrine effects of the novel ghrelin receptor inverse agonist PF-5190457: Results from a placebo-controlled human laboratory alcohol co-administration study in heavy drinkers.

Mary R Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.